Polypoidal choroidal vasculopathy: definition, pathogenesis, diagnosis, and management
CMG Cheung, TYY Lai, P Ruamviboonsuk, SJ Chen… - Ophthalmology, 2018 - Elsevier
Polypoidal choroidal vasculopathy (PCV) is an age-related macular degeneration (AMD)
subtype and is seen particularly in Asians. Previous studies have suggested disparity in …
subtype and is seen particularly in Asians. Previous studies have suggested disparity in …
Age-related macular degeneration and polypoidal choroidal vasculopathy in Asians
Age-related macular degeneration (AMD) is the leading cause of irreversible blindness in
elderly people globally. It is estimated that there will be more Asians with AMD than the rest …
elderly people globally. It is estimated that there will be more Asians with AMD than the rest …
Pachychoroid spectrum disease
S Borooah, PY Sim, S Phatak, G Moraes… - Acta …, 2021 - Wiley Online Library
Recent improvements in ophthalmic imaging have led to the identification of a thickened
choroid or pachychoroid to be associated with a number of retinal diseases. The number of …
choroid or pachychoroid to be associated with a number of retinal diseases. The number of …
Initial versus delayed photodynamic therapy in combination with ranibizumab for treatment of polypoidal choroidal vasculopathy: the Fujisan study
F Gomi, Y Oshima, R Mori, M Kano, M Saito… - Retina, 2015 - journals.lww.com
Purpose: To compare the 1-year results of initial or deferred photodynamic therapy (PDT)
combined with intravitreal ranibizumab (IVR) for eyes with polypoidal choroidal …
combined with intravitreal ranibizumab (IVR) for eyes with polypoidal choroidal …
Polypoidal choroidal vasculopathy in Asians
Age related macular degeneration (AMD) in Asians has been suggested to differ from their
Western counterparts in terms of epidemiology, pathogenesis, clinical presentation and …
Western counterparts in terms of epidemiology, pathogenesis, clinical presentation and …
One-year result of aflibercept treatment on age-related macular degeneration and predictive factors for visual outcome
Purpose To investigate the efficacy of periodic injection of aflibercept in each subtype of age-
related macular degeneration (AMD) and to explore the predictive factors for visual outcome …
related macular degeneration (AMD) and to explore the predictive factors for visual outcome …
Intravitreal anti-vascular endothelial growth factor therapies for retinal disorders
A Hang, S Feldman, AP Amin, JAR Ochoa, SS Park - Pharmaceuticals, 2023 - mdpi.com
Vascular endothelial growth factors (VEGFs) are key mediator of retinal and choroidal
neovascularization as well as retinal vascular leakage leading to macular edema. As such …
neovascularization as well as retinal vascular leakage leading to macular edema. As such …
Polypoidal choroidal vasculopathy: Pearls in diagnosis and management
G Anantharaman, J Sheth, M Bhende… - Indian journal of …, 2018 - journals.lww.com
Polypoidal choroidal vasculopathy (PCV) is increasingly recognized as an important cause
of exudative maculopathy in Asians as against Wet age-related macular degeneration in …
of exudative maculopathy in Asians as against Wet age-related macular degeneration in …
Three-year results of polypoidal choroidal vasculopathy treated with photodynamic therapy: retrospective study and systematic review
Purpose: To evaluate the 3-year outcome in eyes with polypoidal choroidal vasculopathy
(PCV) treated with photodynamic therapy with verteporfin. Methods: Retrospective study and …
(PCV) treated with photodynamic therapy with verteporfin. Methods: Retrospective study and …
Effect of polyp regression and reduction on treatment efficacy in polypoidal choroidal vasculopathy treated with aflibercept
K Sayanagi, S Fujimoto, C Hara, Y Fukushima… - Scientific Reports, 2024 - nature.com
Intravitreal injection of aflibercept (IVA) has successfully treated polypoidal choroidal
vasculopathy (PCV), and polyp morphology is an important indicator of treatment efficacy …
vasculopathy (PCV), and polyp morphology is an important indicator of treatment efficacy …